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Chlamydia trachomatis is an obligate intracellular bacterium associated with trachoma
and sexually transmitted diseases. During its intracellular developmental cycle,
Chlamydia resides in a membrane bound compartment called the inclusion. A subset
of Type III secreted effectors, the inclusion membrane proteins (Inc), are inserted into
the inclusion membrane. Inc proteins are strategically positioned to promote inclusion
interaction with host factors and organelles, a process required for bacterial replication,
but little is known about Inc proteins function or host interacting partners. Moreover,
it is unclear whether each Inc protein has a distinct function or if a subset of Inc
proteins interacts with one another to perform their function. Here, we used IncD as
a model to investigate Inc/Inc interaction in the context of Inc protein expression in
C. trachomatis. We developed a co-infection model system to display different tagged
Inc proteins on the surface of the same inclusion. We also designed chimeric Inc proteins
to delineate domains important for interaction. We showed that IncD can self-interact and
that the full-length protein is required for dimerization and/or oligomerization. Altogether
our approach can be generalized to any Inc protein and will help to characterize the
molecular mechanisms by which Chlamydia Inc proteins interact with themselves and/or
host factors, eventually leading to a better understanding of C. trachomatis interaction
with the mammalian host.
Keywords: Chlamydia, inclusion membrane protein, IncD, IncE, chimeric Inc protein, homo- and heterotypic
interaction
INTRODUCTION
Chlamydia trachomatis is an obligate intracellular bacterial pathogen responsible for the most
common preventable blindness from infectious origin and is the leading cause of sexually
transmitted infection of bacterial origin (Schachter, 1999). The ocular and genital tract epithelia
are the primary sites of infection. After entry, C. trachomatis resides in a membrane-bound
compartment, called the inclusion (Moulder, 1991). Within the lumen of the inclusion, the bacteria
undergo a complex developmental cycle alternating between infectious and replicative forms.
During co-evolution with the mammalian host, the C. trachomatis genome was reduced to about
900 open reading frames (ORF) (Stephens et al., 1998) and C. trachomatis has evolved sophisticated
mechanisms to hijack cellular organelles and manipulate cellular pathways to acquire essential
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nutrients (Elwell et al., 2016). Central to these processes is a
bacterial Type III secretion system (T3SS), which allows for the
translocation of bacterial effectors from the bacterial cytosol into
the host cell (Mueller et al., 2014). One family of C. trachomatis
T3SS effectors, are inserted into the inclusion membrane and
referred to as the inclusion membrane proteins (Inc) (Dehoux
et al., 2011; Lutter et al., 2012; Moore and Ouellette, 2014).
Chlamydia inclusion membrane proteins are characterized
by a large bilobed hydrophobic domain containing at least 50
amino acids (Bannantine et al., 2000), and amino- and carboxy-
terminal tails that are presumably exposed on the cytosolic
surface of the inclusion membrane. Based on the presence of
the bilobed hydrophobic domain, the C. trachomatis genome
is predicted to encode up to 60 Inc proteins. The inclusion
membrane localization of a large number of predicted C.
trachomatis Inc proteins has been confirmed using primary
antibodies (Li et al., 2008) or expression of tagged proteins
from the bacteria (Weber et al., 2015). These Type III secreted
effectors are unique toChlamydia and are strategically positioned
to mediate the interaction of the inclusion with cellular factors
and organelles.
Only a few C. trachomatis Inc proteins have been assigned
a host interacting partner and/or a function. IncA is involved
in homotypic fusion of inclusions (Hackstadt et al., 1999).
IncG interacts with 14-3-3ß (Scidmore and Hackstadt, 2001)
and CT229 with Rab4 (Rzomp et al., 2006). IncD interacts
with and recruits the ceramide transfer protein, CERT, to ER-
inclusion membrane contact sites (Derre et al., 2011; Agaisse
and Derre, 2014). CT228 interacts with the myosin phosphatase
target subunit 1 MYPT1 and regulates the mechanisms by which
C. trachomatis egresses from the host cell (Lutter et al., 2013).
CT850 interacts with the dynein light chain DYNLT1 (Mital
et al., 2015). InaC (CT813/CTL0184) mediates the recruitment
of 14-3-3ß, 14-3-3ǫ, and ARF1 to the inclusion membrane and
is involved in actin assembly and Golgi positioning around
the inclusion (Kokes et al., 2015). IncE binds to the sorting
nexins SNX5 and SNX6, and recruits these retromer complex
components to the inclusion, resulting in inclusion membrane
tubulation (Aeberhard et al., 2015; Mirrashidi et al., 2015).
Mirrashidi et al. have also identified putative mammalian
interacting partners for nearly 40 C. trachomatis Inc proteins
(Mirrashidi et al., 2015). The study was performed with the Inc
proteins overexpressed in mammalian cells, so these interactions
remain to be validated during infection, but the study detected
IncD/CERT and CT228/MYPT1 interactions, suggesting that
this human/Inc interactome is a solid foundation to further
investigate the function of C. trachomatis Inc proteins.
It is unclear whether each Inc protein has a distinct function or
if a subset of Inc proteins can act in concert, potentially through
direct interaction. Some Inc proteins are evenly distributed on the
surface of the inclusionmembrane, while others are concentrated
in microdomains. This is best illustrated with IncB, Inc101,
Inc222, and Inc850, which co-localize to discrete punctae of
the inclusion membrane (Mital et al., 2010). Inc222 and Inc850
were shown to interact, suggesting that Inc proteins could form
stable complexes with one another. The homo- or heterotypic
interaction of Inc proteins was independently investigated using
a bacterial two-hybrid system (Gauliard et al., 2015). Inc222
and Inc850 interaction was observed using this experimental
set up, and the data also suggested that IncD interacted with
itself. In addition, IncA, IncG, IncF, CT229 (CTL0481), CT058
(CTL0314), and CT222 (CTL0475) were identified as potential
interacting partners of IncD. While the CT058- and CT222-IncD
interactions were reciprocal, the IncA-, IncG-, IncF-, and CT229-
IncD interactions were unidirectional with this subset of Inc
being able to interact with IncD, but IncD did not interact with
these proteins.
Here we have developed a system to test Inc/Inc homo-
and heterotypic interactions in the context of C. trachomatis
infection and to identify domains that support these interactions.
Our system relies on the homotypic fusion properties of
C. trachomatis inclusions, on the co-infection with C. trachomatis
strains expressing Inc proteins fused to different tags and on the
expression of chimeric Inc proteins.
MATERIALS AND METHODS
Ethics Statement
All genetic manipulations and containment work were approved
by the UVA Biosafety Committee and are in compliance with the
section III-D-1-a of the National Institutes of Health guidelines
for research involving recombinant DNA molecules.
Cell Lines and Bacterial Strains
HeLa cells were obtained from ATCC (CCL-2) and cultured
at 37◦C with 5% CO2 in DMEM high glucose (Invitrogen)
supplemented with 10% heat inactivated FBS (Invitrogen). C.
trachomatis Lymphogranuloma venereum, Type II were obtained
from ATCC (L2/434/Bu VR-902B). Chlamydia propagation and
infection were performed as previously described (Derre et al.,
2007).
Plasmid Construction
Restriction enzymes and T4 DNA ligase were obtained from
New England Biolabs (Ipswich, MA). PCR was performed using
Herculase DNA polymerase (Stratagene). PCR primers were
obtained from Integrated DNA Technologies. All the plasmids
used in this study are derivatives of p2TK2-SW2 mCh(Gro)
(Agaisse and Derre, 2014). They express mCherry under the
control of the groESL operon promoter and terminator, the
TetR repressor and the indicated Inc under the control of
the tetA gene promoter and incDEFG operon terminator. The
p2TK2-SW2 mCh(Gro) Tet IncD-, IncE-, and IncG-3xFLAG
plasmids were described previously (Agaisse and Derre, 2014;
Mirrashidi et al., 2015). p2TK2-SW2 mCh(Gro) Tet IncD-Myc,
CTL0314-3xFLAG, CTL0475-3xFLAG, or IncD/IncE-3xFLAG
chimera were constructed similarly using the primers listed in
Supplementary Table S1.
C. trachomatis Transformation
Our calcium-based transformation protocol was adapted from
Wang et al. (2011) and is described in Agaisse and Derre (2013).
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Immunoblotting
Protein samples were separated by SDS-PAGE and transferred
to nitrocellulose membranes. The membranes were blocked for
1 h at room temperature in 1xPBS containing 0.05% Tween
and 5% Fat-free milk. Primary and HRP-conjugated secondary
antibobies were diluted in 1xPBS containing 0.05% Tween and
5% Fat-free milk and respectively incubated over-night at 4◦C
and 1 h at room temperature. Proteins were detected using
the Amersham ECL western blotting detection reagent as per
manufacturer recommendation and a Biorad ChemiDoc imaging
system.
Immunofluorescence and Microscopy
At the indicated times, HeLa cells seeded onto glass coverslips
were fixed for 30 min in PBS containing 4% paraformaldehyde.
Immunostainings were performed at room temperature.
Antibodies were diluted in PBS containing 0.1% BSA and 0.1%
Triton X-100. Samples were washed with PBS and examined
under an epifluorescence or spinning disc confocal microscope.
Antibodies
The following primary antibodies were used: Mouse monoclonal
anti-FLAG [1:1,000 (IF), 1:20,000 (WB), Sigma], mouse
monoclonal anti-Myc [1:1,000 (IF), 1:1,000 (WB), Cell
Signaling], rabbit polyclonal anti-Actin (1:1,000, Sigma), rabbit
polyclonal anti-tRFP (1:2,000, Evrogen), and rabbit polyclonal
anti-IncA (1:200, kind gift from T. Hackstadt, Rocky Mountain
Laboratories). The following secondary antibodies were used:
Peroxidase-conjugated goat anti-rabbit IgG (1:10,000, Jackson
ImmunoResearch), peroxidase-conjugated goat anti-mouse
IgG (1:10,000, Jackson ImmunoResearch), goat anti-mouse
AlexaFluor 488 or 514 (IF: 1:1,000, Molecular Probes), and goat
anti-rabbit Pacific Blue (IF: 1:1,000, Molecular Probes).
Co-infection and Immunofluorescence
Analysis of Co-infected Cells
Each strain was used at an MOI of 5 to ensure that each
eukaryotic cell would receive at least one of each bacterium
leading to a mixed bacterial population in each inclusion and
the cellular localization of the 3xFLAG- and Myc-tagged Inc
proteins was analyzed by immunofluorescence. In our original
experimental set up, the samples were co-stained with a rabbit
anti-FLAG and a mouse anti-Myc. However, the rabbit anti-
FLAG led to uneven staining of the inclusions (even at higher
concentration). Duplicate coverslips from the same co-infection
were therefore stained with mouse anti-FLAG or mouse anti-
Myc antibodies. Although not ideal, the MOI were carefully
optimized so that, for each co-immunoprecipitation experiment,
100% of the inclusions were positive for both FLAG and Myc.
The samples were not analyzed if it was not the case.
Co-immunoprecipitation
8.105 HeLa cells plated in 6-well tissue culture dishes and infected
with the indicated C. trachomatis strains for 24 h were washed
once with 1x PBS and lysed for 20 min in 300 µl of lysis buffer
[20 mM Tris pH7.5, 150 mM NaCl, 2 mM EDTA, 1%Triton X-
100, 1 mM PMSF and protease inhibitor cocktail (Roche)]. The
lysates were centrifuge at 13,000 rpm for 10 min. An aliquot of
the clarified lysate was collected (Lysate). The clarified lysates
were incubated for 2 h in the presence of 10 µl of anti-FLAGM2
agarose beads (Sigma). The beads were washed three times (20
mM Tris pH7.5, 150 mM NaCl, 2 mM EDTA, 1%Triton X-100)
and the bound proteins were eluted with 15 µl of elution buffer
[20 mM Tris pH7.5, 150 mM NaCl, 2 mM EDTA, 100 µg/ml
3XFLAG peptide (Sigma)]. Ten microliters of the eluted fraction
was collected (IP). All steps were conducted at 4◦C.
Reproducibility
Each experiment was performed at least three times.
Representative results are shown.
RESULTS
To investigate IncD interaction with a subset of Inc proteins in
the context of C. trachomatis infection, we have generated C.
trachomatis strains co-expressing mCherry under a constitutive
promoter and IncD-3xFLAG, IncD-Myc, IncE-3xFLAG, IncG-
3xFLAG, CTL0314-3xFLAG (CT058), or CTL0475-3xFLAG
(CT222) under the control of the anhydrotetracycline (aTc)
inducible promoter. IncG, CTL0314 and CTL0475 were chosen
based on their potential ability to interact with IncD (Gauliard
et al., 2015) and IncE was included as a negative control.
To verify the expression of the constructs, HeLa cells were
infected with the above listedC. trachomatis strains in the absence
or in the presence of aTc and the corresponding cell lysates were
analyzed by western-blot (Figure 1A). Detection of actin and
mCherry respectively confirmed equal cell and bacterial number
in the absence (-aTc) or presence of aTc (+aTc). Anti-FLAG
antibodies were used to detect the respective 3xFLAG tagged
Inc proteins and anti-Myc antibodies were used to detect IncD-
Myc. As expected, in the absence of inducer the proteins were
not expressed (Figure 1A, -aTc), however a signal corresponding
to the expected molecular weight of the respective proteins was
observed in the presence of aTc (Figure 1A,+aTc).
In addition, the inclusion membrane localization of the above
listed 3xFLAG- or Myc-tagged Inc proteins was analyzed by
immuno-fluorescence. For this purpose, HeLa cells infected
with the respective Chlamydia strains in the absence or in the
presence of aTc were fixed 24 h post-infection and stained with
antibodies against the FLAG or Myc tag. The respective Inc
proteins were not detected in the absence of inducer (not shown).
However, in the presence of aTc, 100% of the inclusions were
positive for the respective constructs and the pattern indicated
that, as previously shown for IncD-, IncE-, and IncG-3xFLAG
(Agaisse and Derre, 2014; Mirrashidi et al., 2015), all constructs
localized to the inclusion membrane (Figure 1B). The inclusion
localization of CTL0314-3xFLAG and CTL0475-3xFLAG was
further confirmed by co-staining of the inclusions with an anti-
IncA antibody (Supplementary Figure 1).
To test the potential interaction between IncD and a subset
of Inc proteins during C. trachomatis intracellular developmental
cycle, we took advantage of the homotypic fusion properties
of the C. trachomatis inclusions (Ridderhof and Barnes, 1989;
Agaisse and Derre, 2013). HeLa cells were co-infected with two
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FIGURE 1 | Expression and inclusion localization of the subset of inclusion membrane proteins used in this study. (A) Immuno-blot of cell lysates from
HeLa cells infected with strains of C. trachomatis expressing mCherry constitutively and IncD-, IncE-, IncG-, CTL0314-, CTL0475-3xFLAG (3F), or IncD-Myc under
the control of the aTc inducible promoter. The cells were infected for 24 h in the absence (-aTc) or in the presence (+aTc) of 2 ng/ml aTc and immuno-blot of the
corresponding lysates were probed using antibodies against FLAG or Myc, mCherry, and Actin. (B,C) Confocal micrographs of inclusions of the C. trachomatis strains
listed in (A). The cells were infected in the presence of 2 ng/ml aTc, fixed 24 h post-infection, immunostained with anti-FLAG or anti-Myc antibodies and imaged using
a confocal microscope. A single plane crossing the middle of the inclusion is shown. The left panels correspond to the bacteria (Chlamydia, red) and the middle panels
to the 3xFLAG or Myc signal of the Inc constructs (Inc, green). The merge is shown on the right. Scale bar: 10 µm.
C. trachomatis strains expressing either IncE-3xFLAG or IncD-
Myc. Each strain was used at an MOI of 5 to ensure that each
eukaryotic cell would receive at least one of each bacterium
leading to a mixed bacterial population in each inclusion. The
cellular localization of the IncE-3xFLAG and IncD-Myc proteins
was analyzed by immunofluorescence (Figure 2). Close to 100%
of the inclusions were positive for FLAG (Figure 2, Top Panels)
or Myc (Figure 2, Bottom Panels) when the samples were
immuno-labeled with one or the other antibody. Altogether,
this result confirmed that the co-infection method allows for
the insertion of different Inc proteins into the same inclusion
membrane when the proteins are produced by different strains.
To investigate if IncD could interact with a subset of Inc
proteins, including itself, HeLa cells were co-infected with
the IncD-Myc expressing strain and a strain that expressed
IncE-, IncG-, CTL0314-, CTL0475-, or IncD-3xFLAG, using
the experimental set up described in Figure 2. For each
condition, we confirmed that nearly 100% of the inclusions
were positive for both markers (not shown). The samples
were subjected to co-immuno-precipitation and the results were
analyzed by western-blot (Figure 3). IncE-, IncG-, CTL0314-
, CTL0475-, and IncD-3xFLAG were expressed and efficiently
immuno-precipitated with the anti-FLAG conjugated beads.
IncD-Myc did not co-immuno-precipitate with IncE-, IncG-
, CTL0314-, or CTL0475-3xFLAG, suggesting that IncD does
not interact with these Inc proteins. However, IncD-Myc did
co-immuno-precipitate with IncD-3xFLAG (Figure 3, last lane),
showing that IncD interacts with itself.
We next investigated whether the IncD/IncD interaction was
occurring when the proteins were inserted into the inclusion
membrane or “in vitro” after the cell lysates were prepared and
processed for immuno-precipitation. To address this question,
we compared IncD self-interaction as described above, or after
collecting and co-incubating cell lysates from cells that were
singly infected with either the IncD-3xFLAG strain or the IncD-
Myc strain. IncD self-interaction was observed upon co-infection
(Figure 4, IP lane 3), however the IncD/IncD interaction was not
detected when lysates from singly infected cells were combined
prior immuno-precipitation (Figure 4, IP lane 4).
Altogether, these results indicate that, under our experimental
set up, when C. trachomatis inclusion membrane proteins are
inserted into the inclusion membrane, IncD interacts with itself
but not with IncE, IncG, CTL0314, or CTL0475. Moreover,
the IncD self-interaction was only observed when the IncD
molecules were inserted into the same inclusion membrane.
We next sought to determine the IncD domain(s) mediating
the IncD/IncD interaction. One possible approach would be to
generate various internal, N- and C-terminal truncated variant of
IncD and assay for their self-interaction. However, Inc proteins
secretion through the Chlamydia type III secretion system
requires a N-terminal secretion signal, that, if truncated, would
prevent secretion. Moreover, the central hydrophobic domain,
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FIGURE 2 | Inclusion membrane localization of Inc proteins expressed
by different C. trachomatis strains in a co-infection model system.
Epifluorescence micrographs of HeLa cells co-infected with strains of C.
trachomatis expressing mCherry constitutively and IncE-3xFLAG or IncD-Myc
under the control of the aTc inducible promoter. The cells were infected in the
presence of 2 ng/ml aTc, fixed 24 h post-infection, immunostained with mouse
anti-Myc antibodies (top panels) or mouse anti- FLAG antibodies (bottom
panels) and imaged using an epifluorescence microscope. The left panels
correspond to the bacteria (Chlamydia, red) and the middle panels to the Myc
or FLAG signal of the Inc constructs (Inc, green). The merge is shown on the
right. Scale bar: 50 µm.
that is characteristic of Inc proteins, is most likely required for
their insertion into the inclusion membrane, which would make
its deletion incompatible with insertion of the corresponding Inc
protein variant into the inclusion membrane.
To address these issues, we generated chimeric proteins
between IncD and IncE. IncE was chosen because it does
not interact with IncD (Figure 3) and IncD and IncE have
similar molecular weight and display similar hydropathy profiles
(Figure 5A). Based on IncD and IncE respective hydropathy
profiles, each protein was divided into three domains: The N-
terminal domain (IncD: aa 1–39, IncE: aa 1–38), the hydrophobic
domain (IncD: aa 40–91, IncE: aa 39–90), and the C-terminal
domain (IncD: aa 92–146, IncE: aa 91–132). The following
chimeric constructs were generated: IncDED, IncEED, IncDEE,
IncEDE, IncDDE, and IncEDD where the first, second and third
letter respectively correspond to the N-terminal, hydrophobic,
or C-terminal domain of the respective Inc protein. The
hydropathy profiles of the IncD/IncE chimeric proteins are
shown in Figure 5A, where the IncD domains are indicated
by the red circles. Each chimera was fused to a 3xFLAG
tag and expressed under the control of the aTc inducible
promoter into p2TK2-SW2mCh(Gro) and the corresponding
plasmids were introduced into C. trachomatis. When HeLa
cells were infected with the resulting C. trachomatis strains,
mCherry was constitutively expressed and the IncD/IncE-
3xFLAG chimeric proteins were only detected in the presence of
inducer (Figure 5B). The levels of expression of the chimera were
FIGURE 3 | IncD interacts with itself in the context of C. trachomatis
infection. Lysates from HeLa cells co-infected in the presence of 2 ng/ml aTc
with a strain of C. trachomatis expressing mCherry constitutively and IncD-Myc
under the control of the aTc inducible promoter [CtL2mCh(Gro)TetIncD-Myc]
and a strain of C. trachomatis expressing mCherry constitutively and IncE-,
IncG-, CTL0314-, CTL0475-, or IncD-3xFLAG (3F) under the control of the aTc
inducible promoter [CtL2mCh(Gro)Tet] were immunoprecipitated with
anti-FLAG M2 beads. A portion of the cell lysate (Left Panel, Lysate) and the
immunoprecipitated proteins (Right Panel, IP) were separated by SDS-PAGE
and analyzed by immunoblot (IB) with antibodies against Myc (Top Panels) and
FLAG (Bottom Panels). The molecular weight ladder is shown on the right.
comparable to the one of IncD- or IncE-3xFLAG (Figure 1A)
and the inclusion localization of the constructs was also
confirmed by immunofluorescence (Figure 5C).
If the N-terminal, the hydrophobic, or the C-terminal
domain of IncD is sufficient to mediate IncD self-interaction,
we rationalized that this domain would promote IncD/IncD-
E chimera interaction in our co-infection experimental set
up. To test our hypothesis, HeLa cells were co-infected with
C. trachomatis strains respectively expressing IncD-Myc and
IncD-3xFLAG or IncD-Myc and one of the six IncD/IncE-
3xFLAG chimeric proteins. For each co-infection combination,
we confirmed that nearly 100% of the inclusions were positive
for each construct by immuno-fluorescence (data not shown).
The lysates were subjected to immuno-precipitation using anti-
FLAG antibodies and co-immuno-precipitation of IncD-Myc
was assayed by western-blot (Figure 6). The IncD/IncE-3xFLAG
chimeric proteins were immuno-precipitated as efficiently as
IncD-3xFLAG. As observed before (Figures 3, 4) IncD-Myc co-
immuno-precipitated with IncD-3xFLAG. In addition, IncD-
Myc co-immuno-precipitated with two of the IncD/IncE
chimeric constructs, IncDDE and IncEDD, but the IncD/IncDDE
and IncD/IncEDD interactions were not as robust as the one
observed with IncD/IncD.
Altogether these results confirmed that chimeric Inc proteins
could be engineered and successfully inserted into C. trachomatis
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FIGURE 4 | IncD-IncD interaction occurs on C.trachomatis inclusion
membrane. HeLa cells were singly infected in the presence of 2 ng/ml with a
strain of C. trachomatis expressing mCherry constitutively and IncD-3xFLAG
(3F) or IncD-Myc under the control of the aTc inducible promoter or co-infected
with these two strains (IncD-3F+IncDMyc CoInf). Lysates from singly and
co-infected cells were collected and a fourth sample was prepared by mixing
equal part of lysates from the singly infected cells (IncD-3F+IncDMyc Mix). The
lysates were immunoprecipitated with anti-FLAG M2 beads. A portion of the
cell lysate (Left Panel, Lysate) and the immunoprecipitated proteins (Right
Panel, IP) were separated by SDS-PAGE and analyzed by immunoblot with
antibodies against Myc (Top Panels) and FLAG (Bottom Panels).
inclusion membrane and could be used to dissect the
molecular mechanisms driving Inc/Inc protein interaction. Our
investigation of IncD self-interaction revealed that although
IncD/IncE chimeric proteins containing the N-terminus and
hydrophobic domain (DDE) or the hydrophobic domain and the
C-terminus (EDD) of IncD were able to interact with IncD, it
appears that the full length IncD protein is required for efficient
self-interaction.
DISCUSSION
Inclusion membrane proteins are specific to Chlamydia and are
strategically positioned to mediate inclusion interaction with
host factors and organelles. However, little is known about
Inc proteins interacting partners and/or function. Inc proteins
are difficult to study because of their inherent biochemical
properties. Their large hydrophobic domain complicates protein
purification in a native and soluble state and limits subsequent
in vitro studies to soluble domains (Ronzone and Paumet, 2013;
Ronzone et al., 2014). Up until recently, in the absence of
genetic tools to manipulate Chlamydia, studies have focused
on over-expressing Inc proteins in mammalian cells (Rzomp
et al., 2006; Derre et al., 2011; Mital et al., 2013; Mirrashidi
et al., 2015) or using two-hybrid system in yeast (Scidmore
and Hackstadt, 2001; Rzomp et al., 2006; Lutter et al., 2013;
Mital et al., 2015) or bacteria (Gauliard et al., 2015). While
these studies have led to the identification of Inc proteins
interacting partners and shed light on the putative function of
some Inc proteins, the big caveat of these studies is that the Inc
proteins were not studied in the natural context of the inclusion
membrane, potentially leading to interaction artifacts due to the
absence of lipids and/or bacterial and host proteins that would
normally constitute the natural environment surrounding the Inc
proteins.
With the development of Chlamydia genetic tools (Wang
et al., 2011; Sixt and Valdivia, 2016), it is now possible to express
Inc proteins of interest from the bacteria and to study their roles
in the context of the inclusion membrane (Agaisse and Derre,
2014; Bauler and Hackstadt, 2014; Kokes et al., 2015;Weber et al.,
2015, 2016). We have previously used this method to further
investigate IncD/CERT interaction in the context of the infection
and to confirm the direct role of IncD in CERT recruitment to
the inclusion membrane (Derre et al., 2011; Agaisse and Derre,
2014).
In the current study, we sought to follow up on a bacterial
two-hybrid study suggesting that IncD may interact with itself
and with a subset of Inc proteins (Gauliard et al., 2015). To probe
for Inc/Inc interaction in the context of C. trachomatis infection,
we took advantage of the fact that nascent inclusions originating
from bacteria expressing two different Inc protein variants will
eventually undergo fusion resulting in inclusions that display
both Inc proteins on the surface of their membranes.
We were able to detect IncD/IncD interaction indicating that
IncD may act as a dimer or an oligomer. Our data are also
consistent with IncD self-interaction occurring only when the
protein is inserted into the inclusion membrane. In the light
of our previous data, showing that IncD interacts with the PH
domain of CERT (Derre et al., 2011; Agaisse and Derre, 2014),
one could envision that IncD dimerization or oligomerization
may enhance the efficacy of CERT recruitment to the inclusion.
In ourmodel system, we did not detect the IncD/CTL0314 and
IncD/CTL0475 interactions previously observed in a bacterial
two-hybrid system. There are two possible explanations to this
discrepancy: (1) we failed to detect these interactions under our
experimental set up or (2) the interactions observed using the
bacterial two-hybrid system were not physiologically relevant.
These results emphasize the need of validating any Inc/Inc
interaction by different approaches, preferably in the context of
infected cells.
If IncD self-interacts, what are the domains driving this
interaction? IncD is a 15 kDa protein that can be separated
into three major domains: A N-terminal domain (aa1–
39) that contains the Type III secretion signal, a central
hydrophobic domain (aa40–91) responsible for inclusion
membrane anchoring and a C-terminal domain (aa92–146).
Both the N- and C-terminal domains are predicted to face the
cytosol. To study IncD variants, that are potentially defective
for IncD/IncD interaction, in the context of the inclusion
membrane, these variants should retain the Type III secretion
signal and the hydrophobic domain for inclusion membrane
localization.
Given that IncD is a fairly small protein, the type of truncated
variants that can be generated and studied is therefore limited.
We did generate a variant of IncD that lacked the C-terminal
domain, but although the corresponding protein was expressed
in C. trachomatis, it failed to display strong inclusion localization
(data not shown).
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FIGURE 5 | IncD/IncE chimeric proteins localize to C. trachomatis inclusion membrane. (A) Hydropathy plots of IncD, IncE, and the IncD/IncE chimeric
proteins used in this study. The red circles indicate domains of IncD. (B) Immuno-blot of cell lysates from HeLa cells infected with strains of C. trachomatis expressing
mCherry constitutively and the indicated IncD/IncE-3xFLAG (3F) chimeric proteins under the control of the aTc inducible promoter. The cells were infected for 24 h in
the absence (-aTc) or in the presence (+aTc) of 2 ng/ml aTc and immuno-blot of the corresponding lysates were probed using antibodies against FLAG, mCherry, and
Actin. (C) Confocal micrographs of inclusions of the C. trachomatis strains listed in (B). The cells were infected in the presence of 2 ng/ml aTc, fixed 24 h
post-infection, immunostained with anti-FLAG antibodies and imaged using a confocal microscope. A single plane crossing the middle of the inclusion is shown. The
left panels correspond to the bacteria (Chlamydia, red) and the middle panels to the FLAG signal of the IncD/IncE chimera (Inc, green). The merge is shown on the
right. Scale bar: 10 µm.
We therefore turned to chimeric Inc proteins that contained
various permutations of the N-, C-terminal, and hydrophobic
domains of IncD and IncE, another small Inc protein that
did not interact with IncD. Only two chimeras were able
to interact with IncD. The combination of the N-terminal
and hydrophobic domains of IncD (DDE) led to weak
interaction and the hydrophobic domain combined to the
C-terminal domain (EDD) led to a slightly more efficient
binding. The efficacy of binding of these two chimeric proteins
was however weaker than the one observed with the full-
length protein. Our data suggest that the full-length IncD
protein is required for dimerization and/or oligomerization.
Alternatively, the hydrophobic domain may be sufficient to
mediate IncD self-interaction but optimal self-interaction may
require additional amino acids that were not included in our
constructs, to accommodate optimal self-interaction. Finally, it
is possible that, although the hydrophobic domain is sufficient to
mediate IncD self-interaction, oligomers formed less efficiently
between un-identical IncD units. Testing the self-interaction
of the IncDDE and IncEDD chimera could address this
question.
Our data suggest that, if not the full-length protein, a large
portion of IncD is required for self-interaction and potentially
for function. This would be in contrast with IncE, which has
been proposed to be a monomer (Gauliard et al., 2015) and for
which the C-terminal domain is sufficient for binding the PX
domain of SNX5 and SNX6 (Mirrashidi et al., 2015). Altogether,
one could envision that some Inc proteins, such as IncE, act as
monomers and have distinct domains dedicated to interaction
with host factors, while others, like IncD, require oligomerization
of the full-length protein to efficiently recruit their host target to
the inclusion membrane.
With the recent advances in Chlamydia genetics, it is now
possible to investigate the role of C. trachomatis inclusion
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FIGURE 6 | IncD-IncD self-interaction requires full length IncD. Lysates
from HeLa cells co-infected in the presence of 2 ng/ml aTc with a strain of C.
trachomatis expressing mCherry constitutively and IncD-Myc under the control
of the aTc inducible promoter [CtL2mCh(Gro)TetIncD-Myc] and strain of C.
trachomatis expressing mCherry constitutively and the indicated
IncD/IncE-3xFLAG (3F) chimera under the control of the aTc inducible
promoter [CtL2mCh(Gro)Tet] were immunoprecipitated with anti-FLAG M2
beads. A portion of the cell lysate (Left Panel, Lysate) and the
immunoprecipitated proteins (Right Panel, IP) were separated by SDS-PAGE
and analyzed by immunoblot (IB) with antibodies against Myc (Top Panels) and
FLAG (Bottom Panels).
membrane proteins in the context of an infected cell. The
co-infection system described here and the use of chimeric Inc
proteins, together with the generation of C. trachomatis strains
lacking Inc proteins of interest will be powerful tools to assay not
only Inc protein functions, but also themolecular mechanisms by
which Inc proteins interact with themselves or with host factors,
ultimately leading to a better understanding of Chlamydia life
cycle and interaction with the mammalian host.
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